BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 3066145)

  • 1. Oncogene activation in chemical carcinogenesis.
    Balmain A; Brown K
    Adv Cancer Res; 1988; 51():147-82. PubMed ID: 3066145
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of oncogenes in chemical carcinogenesis.
    Stowers SJ; Maronpot RR; Reynolds SH; Anderson MW
    Environ Health Perspect; 1987 Nov; 75():81-6. PubMed ID: 3319570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation in ras proto-oncogenes and malignancy.
    Marshall CJ
    J UOEH; 1989 Mar; 11 Suppl():398-405. PubMed ID: 2664953
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of cellular oncogenes by chemical carcinogens in Syrian hamster embryo fibroblasts.
    Ebert R; Barrett JC; Wiseman RW; Pechan R; Reiss E; Röllich G; Schiffmann D
    Environ Health Perspect; 1990 Aug; 88():175-8. PubMed ID: 2272311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of oncogenes by chemical modification with carcinogens].
    Hashimoto Y; Shudo K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3354-64. PubMed ID: 3098180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in expression of onco- and suppressor genes in peripheral leukocytes--as potential biomarkers of chemical carcinogenesis.
    Gyöngyi Z; Ember I; Kiss I; Varga C
    Anticancer Res; 2001; 21(5):3377-80. PubMed ID: 11848497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors.
    Maronpot RR; Fox T; Malarkey DE; Goldsworthy TL
    Toxicology; 1995 Aug; 101(3):125-56. PubMed ID: 7676462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipain-induced suppression of oncogene expression in H-ras-transformed NIH3T3 cells.
    Cox LR; Motz J; Troll W; Garte SJ
    Cancer Res; 1991 Sep; 51(18):4810-4. PubMed ID: 1893373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide.
    Marshall CJ; Vousden KH; Phillips DH
    Nature; 1984 Aug 16-22; 310(5978):586-9. PubMed ID: 6431299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oncogenes on the resistance to cis-diamminedichloroplatinum(II) and metallothionein gene expression.
    Yamada-Okabe T; Yamada-Okabe H; Kashima Y; Doi R
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):233-8. PubMed ID: 7645018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes.
    Stanley LA
    Toxicology; 1995 Feb; 96(3):173-94. PubMed ID: 7900159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of cell transformation systems for carcinogenicity testing and mechanistic studies of carcinogenesis.
    Barrett JC; Hesterberg TW; Thomassen DG
    Pharmacol Rev; 1984 Jun; 36(2 Suppl):53S-70S. PubMed ID: 6473503
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.
    Yuspa SH; Kilkenny A; Cheng C; Roop D; Hennings H; Kruszewski F; Lee E; Strickland J; Greenhalgh DA
    Environ Health Perspect; 1991 Jun; 93():3-10. PubMed ID: 1773799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical mechanisms of the activation of oncogenes through carcinogens.
    Ladik JJ
    Prog Clin Biol Res; 1985; 172A():343-56. PubMed ID: 3991682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
    Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
    Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare frequency of activation of the Ki-ras gene in rat colon tumors induced by heterocyclic amines: possible alternative mechanisms of human colon carcinogenesis.
    Kakiuchi H; Ushijima T; Ochiai M; Imai K; Ito N; Yachi A; Sugimura T; Nagao M
    Mol Carcinog; 1993; 8(1):44-8. PubMed ID: 8352890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene and chemical inhibition of gap-junctional intercellular communication: implications for teratogenesis and carcinogenesis.
    Trosko JE; Chang CC
    Prog Clin Biol Res; 1986; 209B():21-31. PubMed ID: 3749078
    [No Abstract]   [Full Text] [Related]  

  • 20. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
    Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
    Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.